Suppliers / Heraeus Precious Metals GmbH

Heraeus Precious Metals GmbH

Germany 3 employees Updated 9 July 2026

Heraeus Precious Metals GmbH is a contract manufacturer based in Germany. It holds 8 active US drug master files across a filed portfolio of 7 molecules. Its GMP standing is certified by ZLG (DE). Its most recent recorded inspection, by US FDA, closed on 5 August 2022 as VAI.

8
active US DMFs
0
valid CEPs
2
registered plants 1 with an FDA FEI number
0
filings across 0 regulators
These figures were checked against the regulators' own files on 25 July 2026
Plants
1 of 1 confirmed
Inspections
4 of 4 confirmed
Sources: FDA Establishment Registration, read 4 May 2026. FDA drug inspection classifications, read 4 May 2026.

Inspection history

  • 5 August 2022 VAI US FDA
  • 18 May 2018 VAI US FDA
  • 7 March 2014 NAI US FDA
  • 4 March 2010 NAI US FDA

NAI means no action indicated, VAI means voluntary action indicated, and OAI means official action indicated.

Registered plants

Site FDA FEI
Hanau, Germany Not on file
Germany, Germany 3002808476

What they file, and where

Molecule Regulators Docs
Oxaliplatin SFDA (Saudi Arabia), US FDA 3
Aminolevulinic Acid US FDA 1
Bendamustine US FDA 1
Carboplatin US FDA 1
Cisplatin US FDA 1
Dacarbazine US FDA 1
Thiotepa US FDA 1

Also appears on these molecule pages

Filings and GMP by regulator

Regulator Filings GMP certificates
ZLG (DE) None 4

Comparing suppliers?

Choose your molecules and target markets. Heraeus Precious Metals GmbH comes back tiered against every other supplier able to file there.

Start for free
No sales call.

Open risk flags

  • The most recent inspection outcome was VAI, on 5 August 2022.

Sources on this page

FDA
Drug master files, establishment registration, inspection classifications
EDQM
Certificates of suitability
EudraGMDP and national regulators
GMP certificates